Background Hepatitis C virus is a worldwide problem. Noninvasive methods for liver fi brosis assessment as ultrasound-based approaches have emerged to replace liver biopsy. Th e aim of this study was to evaluate the diagnostic accuracy of real-time elastography (RTE) in the assessment of liver fi brosis in patients with chronic hepatitis C (CHC), compared with transient elastography and liver biopsy.
Introduction
Hepatitis C virus (HCV) is a global disease with serious eff ects [1] . Th e highest prevalence of HCV infection (14.7%) is reported in Egypt [2] , mostly by genotype 4 (90%) [3] . Liver fi brosis is part of the structural and functional alterations in HCV-related chronic liver diseases (CLD). Moreover, in chronic hepatitis C (CHC), prognosis and management is infl uenced mainly by the extent of fi brosis [4] .
Although liver biopsy remains the gold standard for hepatic fi brosis assessment, it is painful and invasive, with rare but potentially life-threatening complications in addition to some limitations of this technique including interobserver variation and sampling variability which may lead to understaging of cirrhosis [5] [6] [7] . Furthermore, liver biopsy cannot be used for mass screening in a country with a very high prevalence of HCV like Egypt.
Limitations of the liver biopsy have motivated research for noninvasive methods for measuring hepatic fi brosis that are less invasive and of equal accuracy [8] . Transient elastography (TE) has emerged as the noninvasive method of reference. It is the most widely used and validated technique that measures liver stiff ness based on using elastic shear waves emitted from the vibrator attached to the ultrasound transducer probe. Pulse-echo ultrasound acquisitions follow the shear waves, and the velocity of such waves, directly related to tissue stiff ness, is measured. Th e harder the tissue, the faster the shear wave propagates [8, 9] . However, it cannot be applied in obese and patients with ascites [10] . Failure to obtain any measurement had been reported in 3.1% of cases and unreliable results (not meeting the manufacturer's recommendations) were reported in 15.8% [11] . Failure to obtain any measurement and unreliable results rates were 2.7% and 11.6% respectively as reported by another study [12] .
Real-time elastography (RTE) is technically diff erent from FibroScan. It captures 2-dimensional (2D) strain images induced by internal heartbeats, and the strain images show progressively increasing patchiness with increasing severity of hepatic fi brosis [13, 14] . Th erefore, it can be used in obese patients and those with ascites [15] .
In the current study, we aimed to evaluate the value of RTE for the assessment of liver fi brosis in Egyptian patients with HCV-related CLD. RTE results were compared with fi brosis stage obtained by assessing liver biopsy by METAVIR scoring system, TE and aspartate aminotransferase (AST) to platelet ratio index (APRI).
Patients and methods
Th is prospective study was conducted in 50 CHC patients, recruited from the outpatient clinics of the National Hepatology and Tropical Medicine Research Institute, Egypt. All patients were positive for HCV antibodies and HCV RNA by polymerase chain reaction (PCR). All patients with hepatitis B virus (HBV) co-infection, decompensated liver disease, hepatocellular carcinoma, history of previous antiviral therapy, body mass index (BMI) >30 and presence of absolute contraindication for liver biopsy were excluded from this study. An informed written consent was obtained from all patients according to the 1975 Helsinki Declaration.
All patients were subjected to detailed history, thorough clinical examination, and basic laboratory tests including: complete blood count, AST, alanine aminotransferase, alkaline phosphatase, serum albumin, total bilirubin, INR, α-fetoprotein, hepatitis seromarkers for HCV (anti-HCV) and HBV (HBsAg, anti HBc, and anti-HBs) using ELISA technique. HCV RNA was tested by quantitative PCR. Th e APRI index was calculated as follows: AST (/upper limit of normal range) × 100/platelet count (10 9 /L) [16] . All patients were then subjected to abdominal ultrasonography and liver stiff ness measurments using TE (FibroScan, Echosens, France) and RTE (Hitachi, Hi vision Avius, Linear probe (EUP -L 52). TE TE (FibroScan, Echosens, Paris, France) was used following the technical background and examination procedure as described previously [17] [18] [19] . Interquartile range was lower than 30%. Results were expressed in kilopascals (kPa). Th e median value of 10 successful measurements was considered as the representative of the liver stiff ness of the median value. All examinations were performed by a single experienced operator.
RTE
RTE (Hitachi, Hi vision Avius, Linear probe EUP -L 52) was used. Th e tissue elasticity was calculated by the strain and stress of the examined tissue. In fi rst step, the amount of displacement of the refl ected ultrasound echoes before and under compression were measured (stress fi eld). In the second step, a strain fi eld was reconstructed from the measured displacements (strain image). High elasticity areas (i.e. soft tissue) showed as places of high strain and low elasticity areas (i.e. hard tissue) showed as places of low strain. Ten valid measurements were performed in each subject and recorded as color-coded images.
Ultrasound-guided liver biopsies were performed within a week of liver stiff ness measurements. All samples were examined by a single pathologist, blind to the results of the elastography-based techniques. Th e grade of activity was evaluated using a modifi ed hepatic activity index: mild (0-6), moderate (7) (8) (9) (10) (11) (12) and severe (13) (14) (15) (16) (17) (18) . Fibrosis was staged according to the METAVIR scoring system from F0 to F4 [20] . Based on the results obtained from histopathological assessment of their liver biopsies, patients were divided into two groups: the signifi cant fi brosis group (F ≥2) (n=26), and the nonsignifi cant fi brosis group (F <2) (n=24).
Statistical analysis
Continuous data were presented as mean ± standard deviation while categorical data were presented as number (percent). A P value less than 0.05 was considered statistically signifi cant. All statistical calculations were done using computer programs SPSS (Statistical Package for the Social Science) for Microsoft Windows. Th e diagnostic performance of TE and RTE were assessed by comparison with liver histology and by measuring the area under the receiveroperating characteristics (AUROC). Diagnostic accuracy was also evaluated by comparing the sensitivity, specifi city, positive and negative predictive values (PPV and NPV respectively).
Results
Th e present study was conducted on 50 HCV patients. Th eir age ranged from 27-65 years. Th e mean age was 44.2±12. Demographic features, laboratory data and histopathological features of the included patients are shown in Table 1 .
Th e analysis of the accuracy of RTE, FibroScan and APRI in predicting liver fi brosis in 50 HCV patients is shown in Table 2 . At cut-off value 7.5 KPa, FibroScan could diagnose signifi cant fi brosis (F ≥2) with sensitivity 88%, specifi city 100%, PPV 100%, NPV 89.3%, and AUROC 0.94 (Table 2, Fig. 1 ). RTE could diagnose signifi cant fi brosis (F ≥2) at cut-off value 2.49 with sensitivity 100%, specifi city 66%, PPV 74.6%, NPV 100%, and AUROC 0.8 (Table 2, Fig. 2) . APRI, at cut off value 0.65, could predict signifi cant fi brosis (F ≥2) with sensitivity 54%, specifi city 80%, PPV 72.9%, NPV 63.5%, and AUROC 0.69 (Table 2, Fig. 3 ). Th ere was a signifi cant positive correlation between the FibroScan score and RTE score (r=0.6, P=0.001) (Fig. 4) .
Discussion
Ultrasonography-based noninvasive approaches are increasingly considered to assess parenchymal stiff ness and progression of CLD [21] . FibroScan measures the propagation speed of shear waves [22] [23] [24] . RTE captures 2D strain images induced by internal heart beats, and the strain images show progressively increasing patchiness with increasing severity of fi brosis [13, 14] . Th erefore, it is possible to perform in obese patients or with ascites. In the current study, the diagnostic accuracy of RTE and TE in assessing signifi cant liver fi brosis was compared against histopathology in CHC patients with BMI ≤30.
In CHC patients, prognosis and management strongly depend on the degree of liver fi brosis [4] . Treatment should be initiated promptly in those with severe fi brosis (F3-F4) and should be strongly considered in CHC patients with signifi cant fi brosis (F >2). Our study showed that TE was able to diagnose the presence of signifi cant fi brosis at a cut off value of 7.5 kPa with a sensitivity of 88%, specifi city of 100%, PPV 100%, and NPV 89.3%. Th e overall accuracy was found to be 94% with no failure of TE was recorded. Th is high diagnostic performance of TE was probably explained by exclusion of patients with BMI >30 from this study. Likewise, previous studies showed that the AUROCs ranged from 0.79 to 0.83 for the prediction of signifi cant hepatic fi brosis and were over 0.95 for the identifi cation of cirrhosis [25, 26] .
Other studies reported that TE showed a good diagnostic performance in predicting signifi cant fi brosis, and disease progression to advanced fi brosis and cirrhosis when compared to other noninvasive tests [25, [27] [28] [29] [30] . Friedrich-Rust et al [29] assessed the overall performance of TE for the diagnosis of liver fi brosis; the AUROCs were 0.84 for signifi cant fi brosis (F ≥2), 0.89 for severe fi brosis (F ≥3), and 0.94 for the diagnosis of cirrhosis (F=4).
RTE had been reported to be useful for assessment of hepatic fi brosis in patients with CHC while is not in patients with nonalcoholic fatty liver disease [15] . In the work of Tatsumi et al (2008) , RTE correlated well with liver stiff ness measured by FibroScan [31] . In our study, RTE was able to diagnose signifi cant fi brosis (≥F2) with a sensitivity of 100%, specifi city of 66%, and an overall accuracy of 83%. Although inferior to TE in determining signifi cant hepatic fi brosis, RTE still showed a highly signifi cant positive correlation with TE (P=0.001). Th us, RTE may be useful for assessing hepatic fi brosis in patients for whom the application of FibroScan may be limited.
FibroScan had some limitations in special patients [32] . Furthermore, examination with FibroScan oft en requires the use of ultrasonography to fi nd the good window because there is no B-mode and around 20% of the cases, reliable measurements cannot be obtained by TE using the standard M-probe [11] . On the contrary, RTE displays in real time the relative strain of the tissue by measuring its displacement and it can easily fi nd the most appropriate region and capture the value. Better results may be achieved by a combination of FibroScan (a technology based on shear wave propagation) and RTE (a technology based on tissue distortion).
In the current study, APRI at cutoff value 0.65 could predict signifi cant fi brosis (F ≥2) with sensitivity 54%, specifi city 80% and AUROC 0.69; at cut-off 0.5 the sensitivity was 65.4% and specifi city was 66.7%, and at cutoff 1.5 the sensitivity was 30.8% and specifi city of 100%. Th e diagnostic accuracy of APRI in the current study was lower than previous studies comparing APRI with FibroScan or FibroTest [16, 25, 33] . suggested that real-time strain elastography can be used in the same way as TE is being used for the assessment of severe fi brosis and cirrhosis, with the benefi t of improved assessment of signifi cant fi brosis as no signifi cant diff erence was observed between AUROCs of TE and real-time SWE for severe fi brosis (0.96 and 0.98, respectively) [34] .
In conclusion, although FibroScan is superior in determining signifi cant hepatic fi brosis, our data suggest that 
Summary Box
What is already known:
• Noninvasive methods for liver fi brosis assessment as ultrasound-based approaches have emerged to replace liver biopsy • FibroScan is the most widely used and proved technique that measures liver stiff ness based on the propagation speed of shear waves • Real-time elastography (RTE) is technically diff erent (a technology based on tissue distortion)
What the new fi ndings are:
• Th e overall diagnostic accuracy of FibroScan was found to be 94%, while in RTE it was 83% • Although RTE was less than FibroScan in determining signifi cant liver fi brosis, our data suggest that RTE may be a useful for liver fi brosis assessment in chronic hepatitis C patients especially in cases with technical limitations for FibroScan • Th ere was a signifi cant positive correlation between the FibroScan score and RTE score (r=0.6, P=0.001) RTE may be a useful and promising noninvasive method for liver fi brosis assessment in CHC patients, especially in cases with technical limitations for FibroScan.
